Meeting
2023 ASCO Annual Meeting
HER2-low breast cancer brain metastases: Incidence and treatment implications.
Authors
Rania Chehade
University of Toronto, Sunnybrook Hospital, Toronto, ON, Canada
Rania Chehade , Sharon Nofech-Mozes , Anna Plotkin , Veronika Moravan , Katarzyna Joanna Jerzak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2035)
DOI
10.1200/JCO.2023.41.16_suppl.2035
Abstract #
2035
Poster Bd #
392
Abstract Disclosures
Similar Posters
First Author: Assumpció López-Paradís
Poster
2021 ASCO Annual Meeting
Clinical and pathological characteristics of breast cancer with resected brain metastasis.
First Author: Shiyuan Anabeth Liu
Poster
2015 ASCO Annual Meeting
Correlation of trastuzumab treatment benefit with quantitative HER2 expression levels in HER2 positive metastatic breast cancer.
First Author: Beatrice Bachmeier
Poster
2023 ASCO Annual Meeting
Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from triple negative breast cancer or HER2+ breast cancer.
First Author: Shipra Gandhi